Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61


Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team.

N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922.


Treatment interruption in HIV-positive patients followed up in Cameroon's antiretroviral treatment programme: individual and health care supply-related factors (ANRS-12288 EVOLCam survey).

Tong C, Suzan-Monti M, Sagaon-Teyssier L, Mimi M, Laurent C, Maradan G, Mengue MT, Spire B, Kuaban C, Vidal L, Boyer S; EVOL Cam group.

Trop Med Int Health. 2018 Mar;23(3):315-326. doi: 10.1111/tmi.13030. Epub 2018 Feb 2.


Cryptococcal meningitis: A neglected NTD?

Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A.

PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005575. doi: 10.1371/journal.pntd.0005575. eCollection 2017 Jun. No abstract available.


Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.

Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group.

Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.


Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects.

Fonsah JY, Njamnshi AK, Kouanfack C, Qiu F, Njamnshi DM, Tagny CT, Nchindap E, Kenmogne L, Mbanya D, Heaton R, Kanmogne GD.

PLoS One. 2017 Jan 31;12(1):e0170893. doi: 10.1371/journal.pone.0170893. eCollection 2017.


Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets.

Boullé C, Guichet E, Kouanfack C, Aghokeng A, Onambany B, Ikaka CM, Ngock E, Tsoumsta L, Msellati P, Mpoudi-Ngolé E, Peeters M, Delaporte E, Laurent C.

Open Forum Infect Dis. 2016 Dec 20;3(4):ofw233. doi: 10.1093/ofid/ofw233. eCollection 2016 Oct.


Genetic diversity of the Hwp1 gene and HIS3, EF3, CDC3 microsatellites and antifungal susceptibility profiles of Candida albicans isolates from Yaoundé HIV-infected patients.

Ngouana TK, Drakulovski P, Krasteva D, Toghueo RK, Kouanfack C, Reynes J, Delaporte E, Boyom FF, Mallié M, Bertout S.

Med Mycol. 2017 Jul 1;55(5):546-554. doi: 10.1093/mmy/myw108.


Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.

Teto G, Fonsah JY, Tagny CT, Mbanya D, Nchindap E, Kenmogne L, Fokam J, Njamnshi DM, Kouanfack C, Njamnshi AK, Kanmogne GD.

Viruses. 2016 Jul 18;8(7). pii: E196. doi: 10.3390/v8070196.


Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient.

Kammalac Ngouana T, Drakulovski P, Krasteva D, Kouanfack C, Reynes J, Delaporte E, Boyom FF, Mallié M, Bertout S.

J Med Microbiol. 2016 Jul;65(7):579-89. doi: 10.1099/jmm.0.000265. Epub 2016 Apr 20.


Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.

Fokam J, Takou D, Santoro MM, Akonie HZ, Kouanfack C, Ceccherini-Silberstein F, Colizzi V, Perno CF, Ndjolo A.

AIDS Res Hum Retroviruses. 2016 Apr;32(4):329-33. doi: 10.1089/AID.2015.0065. Epub 2016 Jan 20.


Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.

Ciaffi L, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E; 2LADY Study Group.

AIDS. 2015 Jul 31;29(12):1473-81. doi: 10.1097/QAD.0000000000000709.


Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.

Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C; Stratall ANRS 12110ESTHER Study Group.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):355-64. doi: 10.1097/QAI.0000000000000604.


Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy].

Suzan-Monti M, Blanche J, Boyer S, Kouanfack C, Delaporte E, Bonono RC, Carrieri PM, Protopopescu C, Laurent C, Spire B; Stratall ANRS 12110/ESTHER Study Group.

HIV Med. 2015 May;16(5):307-18. doi: 10.1111/hiv.12213. Epub 2015 Feb 27.


Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial.

Bigna JJ, Noubiap JJ, Plottel CS, Kouanfack C, Koulla-Shiro S.

Infect Dis Poverty. 2014 Dec 3;3(1):44. doi: 10.1186/2049-9957-3-44. eCollection 2014.


Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.

Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G; DAYANA Study Group.

J Antimicrob Chemother. 2015 May;70(5):1517-21. doi: 10.1093/jac/dku532. Epub 2015 Jan 11.


Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.

Kammalac Ngouana T, Dongtsa J, Kouanfack C, Tonfack C, Fomena S, Mallié M, Delaporte E, Boyom FF, Bertout S.

J Mycol Med. 2015 Mar;25(1):11-6. doi: 10.1016/j.mycmed.2014.10.016. Epub 2014 Nov 21.


Barriers to the implementation of mobile phone reminders in pediatric HIV care: a pre-trial analysis of the Cameroonian MORE CARE study.

Bigna JJ, Noubiap JJ, Plottel CS, Kouanfack C, Koulla-Shiro S.

BMC Health Serv Res. 2014 Oct 26;14:523. doi: 10.1186/s12913-014-0523-3.


Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients.

Ngouana TK, Krasteva D, Drakulovski P, Toghueo RK, Kouanfack C, Ambe A, Reynes J, Delaporte E, Boyom FF, Mallié M, Bertout S.

Mycoses. 2015 Jan;58(1):33-9. doi: 10.1111/myc.12266. Epub 2014 Oct 7.


A framework for community ownership of a text messaging programme to improve adherence to antiretroviral therapy and client-provider communication: a mixed methods study.

Mbuagbaw L, Bonono-Momnougui RC, Thabane L, Kouanfack C, Smieja M, Ongolo-Zogo P.

BMC Health Serv Res. 2014 Sep 26;14:441. doi: 10.1186/1472-6963-14-441.


Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): a multicentre, single-blind, factorial, randomised controlled trial.

Bigna JJ, Noubiap JJ, Kouanfack C, Plottel CS, Koulla-Shiro S.

Lancet Infect Dis. 2014 Jul;14(7):600-8. doi: 10.1016/S1473-3099(14)70741-8. Epub 2014 Jun 2.


Supplemental Content

Loading ...
Support Center